Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

Nature Communications 8: Article number: 15987 (2017); Published: 11 July 2017; Updated: 13 March 2018 In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following: ‘This work was supp...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Peter J. Cook, Rozario Thomas, Ram Kannan, Esther Sanchez de Leon, Alexander Drilon, Marc K. Rosenblum, Maurizio Scaltriti, Robert Benezra, Andrea Ventura
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2018
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/e3bc39779c1940f3b63041d39757508e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e3bc39779c1940f3b63041d39757508e
record_format	dspace
spelling	oai:doaj.org-article:e3bc39779c1940f3b63041d39757508e2021-12-02T16:56:40ZCorrection: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target10.1038/ncomms161872041-1723https://doaj.org/article/e3bc39779c1940f3b63041d39757508e2018-03-01T00:00:00Zhttps://doi.org/10.1038/ncomms16187https://doaj.org/toc/2041-1723Nature Communications 8: Article number: 15987 (2017); Published: 11 July 2017; Updated: 13 March 2018 In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following: ‘This work was supported by grant I10-0095 from the STARR foundation.Peter J. CookRozario ThomasRam KannanEsther Sanchez de LeonAlexander DrilonMarc K. RosenblumMaurizio ScaltritiRobert BenezraAndrea VenturaNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Peter J. Cook Rozario Thomas Ram Kannan Esther Sanchez de Leon Alexander Drilon Marc K. Rosenblum Maurizio Scaltriti Robert Benezra Andrea Ventura Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
description	Nature Communications 8: Article number: 15987 (2017); Published: 11 July 2017; Updated: 13 March 2018 In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following: ‘This work was supported by grant I10-0095 from the STARR foundation.
format	article
author	Peter J. Cook Rozario Thomas Ram Kannan Esther Sanchez de Leon Alexander Drilon Marc K. Rosenblum Maurizio Scaltriti Robert Benezra Andrea Ventura
author_facet	Peter J. Cook Rozario Thomas Ram Kannan Esther Sanchez de Leon Alexander Drilon Marc K. Rosenblum Maurizio Scaltriti Robert Benezra Andrea Ventura
author_sort	Peter J. Cook
title	Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
title_short	Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
title_full	Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
title_fullStr	Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
title_full_unstemmed	Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
title_sort	correction: author correction: somatic chromosomal engineering identifies bcan-ntrk1 as a potent glioma driver and therapeutic target
publisher	Nature Portfolio
publishDate	2018
url	https://doaj.org/article/e3bc39779c1940f3b63041d39757508e
work_keys_str_mv	AT peterjcook correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT rozariothomas correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT ramkannan correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT esthersanchezdeleon correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT alexanderdrilon correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT marckrosenblum correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT maurizioscaltriti correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT robertbenezra correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget AT andreaventura correctionauthorcorrectionsomaticchromosomalengineeringidentifiesbcanntrk1asapotentgliomadriverandtherapeutictarget
_version_	1718382773069152256

Correction: Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

Ejemplares similares